Baxter Healthcare Corporation

Quick facts

Marketed products

• Clinolipid · Metabolic
• Fibrin Sealant
• multiple electrolyte solution · Critical Care / Fluid and Electrolyte Management
  Multiple electrolyte solution replaces and maintains essential electrolytes (sodium, potassium, calcium, magnesium, chloride, acetate, phosphate) and fluid balance in the body.

Phase 3 pipeline

• Fibrin Sealant VH S/D · Surgery / Hemostasis
  Fibrin Sealant VH S/D is a topical hemostatic agent that forms a fibrin clot to seal wounds and control bleeding during surgery.
• FS VH S/D 4 s-apr · Hematology / Transfusion Medicine
  FS VH S/D 4 s-apr is a solvent/detergent-treated fresh frozen plasma product designed to provide clotting factors and other plasma proteins while reducing the risk of viral transmission.
• FS VH S/D 500 s-apr · Hematology / Transfusion Medicine
  FS VH S/D is a solvent/detergent-treated fresh frozen plasma product that provides multiple clotting factors and plasma proteins for hemostasis support.
• Paracetamol 1% solution · Pain Management
  Paracetamol inhibits prostaglandin synthesis in the central nervous system to reduce pain and fever.
• Ped3CB · Cardiovascular
  Ped3CB is a small molecule that acts as a selective inhibitor of the sodium- potassium pump.
• TISSEEL Lyo · Surgical Hemostasis
  TISSEEL Lyo is a fibrin sealant used to control bleeding.
• TISSEEL VH fibrin sealant · Surgery/Hemostasis
  TISSEEL VH is a fibrin sealant that mimics the final step of the coagulation cascade to form a stable fibrin clot for hemostasis and tissue sealing.

Phase 2 pipeline

• Anti-Adhesion Product

Phase 1 pipeline

• Numeta G16%E
• SC HYLENEX and Ceftriaxone

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Baxter Healthcare Corporation portfolio CI brief
• Baxter Healthcare Corporation pipeline updates RSS